How will we know when we're there?

How to prove a treatment for macular degeneration is actually effective

Age-related macular degeneration (AMD) is a leading cause of legal blindness in Australians over 50. It develops slowly over many years before it threatens sight, often in ways that can be challenging and life-altering.

The key to saving sight is intervening early before vision is threatened. But how do prove that you have slowed down disease progression?

Professor Robyn Guymer AM is CERA’s Deputy Director and Professor of Ophthalmology at the University of Melbourne. She has led CERA’s Macular Research Unit since 1997 and is a world-leading authority on age-related macular degeneration.

In this free, insightful lecture, Professor Guymer will use AMD research to illustrate the complexity around proving that an intervention is successful in slowing a chronic, progressive disease – and the implications this poses for convincing regulators to approve emerging treatments.

In person

5.30pm - 7.30pm AEST

Martin Family Auditorium, Level 4, The Royal Victorian Eye and Ear Hospital, East Melbourne VIC 3002

OR

Livestream

6.15pm - 7.30pm AEST

The livestream access link will be emailed the week prior to the event.

Registrations are essential for in-person or livestream attendance. If you have any issues when registering, please contact CERA via events@cera.org.au or 03 9959 0000.